Biocept Inc (NASDAQ:BIOC) CEO Mike Nall presents to investors at Proactive's One2One Virtual Investor Forum. The group is a commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer.
Biocept - Proactive's One2One Virtual Investor Forum
Quick facts: Biocept Inc
Price: 4.07 USD
Market Cap: $59.92 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE